Compounds > chloroquine

chloroquine and su 11248

chloroquine has been researched along with su 11248 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Abdel-Aziz, AK; Abdel-Naim, AB; El-Demerdash, E; Elgendy, M; Shouman, S1
Bekerman, E; Einav, S1
Abraham, RT; Bray, K; Cochran, N; De Jesus, R; Eng, CH; Fantin, VR; Fitzgerald, SL; Frias, E; George, E; Hoffman, GR; Lemon, L; Liu, S; Lucas, J; McAllister, G; Murphy, LO; Nyfeler, B; Tkach, D; Toral-Barza, L; Ugwonali, S; Wang, Z1
Song, WD; Sun, J; Xi, ZJ; Yan, SY1

Reviews

1 review(s) available for chloroquine and su 11248

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for chloroquine and su 11248

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries.
    Chemico-biological interactions, 2014, Jun-25, Volume: 217

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caco-2 Cells; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Chloroquine; Drug Synergism; Female; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Immunohistochemistry; Indoles; MCF-7 Cells; Mice; Neovascularization, Pathologic; Pyrroles; Sunitinib

2014
Infectious disease. Combating emerging viral threats.
    Science (New York, N.Y.), 2015, Apr-17, Volume: 348, Issue:6232

    Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses

2015
Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, Jan-05, Volume: 113, Issue:1

    Topics: Antineoplastic Agents; Autophagy; Autophagy-Related Protein 7; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chloroquine; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Gene Knockout Techniques; Humans; Indoles; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyrroles; Radiation Tolerance; Sunitinib; Ubiquitin-Activating Enzymes

2016
[Chloroquine inhibits viability of renal carcinoma cells and enhances sunitinib-induced caspase-dependent apoptosis].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2018, Oct-18, Volume: 50, Issue:5

    Topics: Animals; Antineoplastic Agents; Antirheumatic Agents; Apoptosis; Autophagy; Caspases; Cell Line, Tumor; Chloroquine; Kidney Neoplasms; Sunitinib

2018